These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22419128)

  • 1. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
    Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
    Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
    Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
    Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
    Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Mo S; Su Z; Heng B; Chen W; Shi L; Du X; Lai C
    J Nippon Med Sch; 2018; 85(2):78-86. PubMed ID: 29731501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
    Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
    Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
    Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
    J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.
    Serth J; Peters I; Dubrowinskaja N; Reese C; Albrecht K; Klintschar M; Lafos M; Grote A; Becker A; Hennenlotter J; Stenzl A; Tezval H; Kuczyk MA
    Clin Epigenetics; 2020 Feb; 12(1):33. PubMed ID: 32070431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-associated silencing of TU3A in human cancers.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
    Ricketts CJ; Hill VK; Linehan WM
    PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
    Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
    BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.